Essity repurchases 226,401 shares in Essity B stock program

Published on 10/27/2026 at 09:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The October 19-23 buyback lifted program purchases to 7,299,923 shares. Essity B stock costs EUR 24.61 on October 27, 2026, while third-quarter sales reached SEK 36.06 billion.

Buyback expands Essity's share count

Essity reported 226,401 repurchased Class B shares for October 19-23, 2026.
The third-quarter report dated October 22, 2026, showed SEK 36.06 billion in net sales.
Essity B stock traded at EUR 24.61 at 9:07 a.m. CET at Lang & Schwarz on October 27, 2026.

Essity B, SE0009922164, Illustration mit AI erstellt.

Essity repurchased 226,401 Class B shares between October 19, 2026, and October 23, 2026, extending its capital-return program as the company manages weaker organic growth. The latest notice from Nasdaq Stockholm says cumulative purchases reached 7,299,923 Class B shares by October 23, 2026.

Buyback reaches a new stage

The weekly purchases totaled SEK 62.50 million at a weighted average price of SEK 276.0680. Essity held 8,540,046 Class B treasury shares after the transactions, while total shares outstanding stood at 681,945,171.

The program was announced with a SEK 3 billion ceiling and is scheduled to run from May 12, 2026, until the 2027 Annual General Meeting at the latest. The company says the repurchases are financed from operating cash flow after the ordinary dividend.

Quarterly margins remain the key issue

Essity's third-quarter report dated October 22, 2026, put the buyback into a mixed operating picture. According to Essity, net sales rose 4.10 percent year over year to SEK 36.06 billion, but organic sales declined 0.30 percent.

Adjusted EBITA excluding items affecting comparability fell to SEK 4.73 billion from SEK 5.06 billion in the third quarter of 2025. The adjusted EBITA margin declined to 13.10 percent from 14.60 percent, while operating cash flow increased to SEK 5.78 billion from SEK 5.32 billion.

What comes next for the company

The company is also evaluating strategic alternatives for its Consumer Tissue business. Its report says the review is proceeding according to plan, while an agreed acquisition of Kenvue's feminine care business in Brazil is expected to close in the second quarter of 2027, subject to regulatory approval.

Essity B stock was trading at EUR 24.61 at Lang & Schwarz on October 27, 2026, at 9:07 a.m. CET. The primary listing is on Nasdaq Stockholm, where the finance quote showed SEK 274.00 at 10:04 a.m. CET on the same date.

The further course of trading is shown by the continuously updated real-time quote of Essity B stock.